 |
Articles: General Pharma |
Prior Articles
KLAS Assesses Document Mgmt. Apps
HealthDataManagement, 10/30/09
Group: Breach Rule Flouts Congressional Intent
HealthDataManagement, 10/30/09 Premier: Keep Threshold in Breach Rule
HealthDataManagement, 10/30/09 Cardinal Health awarded multi-year surgical glove contract with Novation
Cardinal Health, 10/30/09
Free full text
Adolor Corporation Reports Third Quarter 2009 Financial Results
Adolor Corporation, 10/30/09
Free full text
Gen-Probe Reports Financial Results for Third Quarter 2009
Gen-Probe, 10/30/09
Free full text
Human genome sciences announces third quarter 2009 financial results and key developments
Human Genome Sciences, 10/30/09
Free full text
ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
ImmunoGen, Inc., 10/30/09
Free full text
Repligen Announces Conference Call of Second Quarter Fiscal Year 2010 Results
Repligen, 10/30/09
Free full text
XenoPort to Release Third Quarter Financial Results on November 2009
XenoPort, 10/30/09 Glossary of Genetic Terms Gets Upgrade
HealthDataManagement, 10/30/09 Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
Cell Therapeutics, 10/30/09
Free full text
Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October
Shire, 10/30/09 Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
Abbott, 10/30/09 Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09
Free full text
AHA Endorses Incident Mgmt. App
HealthDataManagement, 10/30/09 Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 10/30/09 Novartis biological drug Ilaris approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease
Novartis, 10/29/09
Free full text
Patients taking VIMOVO showed improved UGI tolerability assessments as compared to EC naproxen
AstraZeneca, 10/29/09
Free full text
Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Nabi Biopharmaceuticals, 10/29/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
